MedTrace Logo

Consequences of COVID 19 Pandemic on Childhood Asthma

NCT04821908 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 577

Last updated 2026-05-14

No results posted yet for this study

Summary

The SARS-CoV2 pandemic, which emerged in the first quarter of 2020, has led to an unprecedented health crisis in our modern healthcare systems and has resulted in strong national public health measures. The impact of the pandemic and its indirect environmental consequences on pediatric asthma is currently being assessed. In particular, the study of its role on the risk of exacerbations and modification of control is one of the priority research objectives defined by European societies.

The primary aim is to study the impact of the pandemic on asthma control in children aged 3-16 years with a medical diagnosis of asthma, compared to data from other observational cohorts conducted in the same region prior to the pandemic.

A sub-population of children 3-16 years will be assessed at exacerbation and at a follow-up visit, 2-4 months later, with clinical data, biological and microbiological samples.

Conditions

  • Asthma in Children

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Stéphanie Lejeune, MD · University Hospital, Lille

Eligibility

Min Age
3 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-14
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04821908 on ClinicalTrials.gov